A novel treatment for relapsed multiple myeloma is showing good results in an international clinical trial, researchers have reported.
The experimental drug, talquetamab, is a bi-specific antibody therapy which redirects the immune system’s T cell...
1 year ago
It feels about 10 minutes ago since I finished writing the November message, but this is a shortened month with the Christmas break approaching fast. As I review the year’s messages I do apologise if they have seemed to take a negative tone. They’...
1 year ago
